Literature DB >> 20700625

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

Julie Lecomte1, Krystel Louis, Benoit Detry, Silvia Blacher, Vincent Lambert, Sandrine Bekaert, Carine Munaut, Jenny Paupert, Pierre Blaise, Jean-Michel Foidart, Jean-Marie Rakic, Stephen M Krane, Agnès Noel.   

Abstract

In this study, we evaluate the potential involvement of collagenase-3 (MMP13), a matrix metalloproteinase (MMP) family member, in the exudative form of age-related macular degeneration characterized by a neovascularisation into the choroid. RT-PCR analysis revealed that human neovascular membranes issued from patients with AMD expressed high levels of Mmp13. The contribution of MMP13 in choroidal neovascularization (CNV) formation was explored by using a murine model of laser-induced CNV and applying it to wild-type mice (WT) and Mmp13-deficient mice (Mmp13 ( -/- ) mice). Angiogenic and inflammatory reactions were explored by immunohistochemistry. The implication of bone marrow (BM)-derived cells was determined by BM engraftment into irradiated mice and by injecting mesenchymal stem cells (MSC) isolated from WT BM. The deficiency of Mmp13 impaired CNV formation which was fully restored by WT BM engraftment and partially rescued by several injections of WT MSC. The present study sheds light on a novel function of MMP13 during BM-dependent choroidal vascularization and provides evidence for a role for MSC in the pathogenesis of CNV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20700625     DOI: 10.1007/s00018-010-0476-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  40 in total

Review 1.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

2.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Authors:  T Asahara; H Masuda; T Takahashi; C Kalka; C Pastore; M Silver; M Kearne; M Magner; J M Isner
Journal:  Circ Res       Date:  1999-08-06       Impact factor: 17.367

3.  Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.

Authors:  V Knäuper; H Will; C López-Otin; B Smith; S J Atkinson; H Stanton; R M Hembry; G Murphy
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

Review 4.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

5.  Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor.

Authors:  Karl G Csaky; Judit Z Baffi; Gordon A Byrnes; Jeremy D Wolfe; Sara C Hilmer; Jessica Flippin; Scott W Cousins
Journal:  Exp Eye Res       Date:  2004-06       Impact factor: 3.467

6.  MMP-2 and MMP-9 synergize in promoting choroidal neovascularization.

Authors:  Vincent Lambert; Ben Wielockx; Carine Munaut; Catherine Galopin; Maud Jost; Takeshi Itoh; Zena Werb; Andrew Baker; Claude Libert; Hans-Willi Krell; Jean-Michel Foidart; Agnès Noël; Jean-Marie Rakic
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

7.  The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.

Authors:  J M Whitelock; A D Murdoch; R V Iozzo; P A Underwood
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

8.  The role of adult bone marrow-derived stem cells in choroidal neovascularization.

Authors:  Nilanjana Sengupta; Sergio Caballero; Robert N Mames; Jason M Butler; Edward W Scott; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  Matrix metalloproteinase-9 contributes to choroidal neovascularization.

Authors:  Vincent Lambert; Carine Munaut; Maud Jost; Agnès Noël; Zena Werb; Jean-Michel Foidart; Jean-Marie Rakic
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 10.  Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.

Authors:  Agnès Noël; Maud Jost; Vincent Lambert; Julie Lecomte; Jean-Marie Rakic
Journal:  Trends Mol Med       Date:  2007-07-17       Impact factor: 11.951

View more
  16 in total

1.  In vivo bioluminescence imaging of hyperglycemia exacerbating stem cells on choroidal neovascularization in mice.

Authors:  Xiang Gao; Yu Wang; Hui-Yuan Hou; Yang Lyu; Hai-Yan Wang; Li-Bo Yao; Jian Zhang; Feng Cao; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration.

Authors:  Hui Zhao; Jayeeta Roychoudhury; Teresa A Doggett; Rajendra S Apte; Thomas A Ferguson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-07       Impact factor: 4.799

3.  Matrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration.

Authors:  Amit K Jha; Kevin M Tharp; Shane Browne; Jianqin Ye; Andreas Stahl; Yerem Yeghiazarians; Kevin E Healy
Journal:  Biomaterials       Date:  2016-03-03       Impact factor: 12.479

4.  Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.

Authors:  Bongsu Kim; Mohamed H Abdel-Rahman; Tiffany Wang; Severin Pouly; Ashraf M Mahmoud; Colleen M Cebulla
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-03       Impact factor: 4.799

5.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

6.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Authors:  Vincent Lambert; Julie Lecomte; Sylvain Hansen; Silvia Blacher; Maria-Luz Alvarez Gonzalez; Ingrid Struman; Nor Eddine Sounni; Eric Rozet; Pascal de Tullio; Jean Michel Foidart; Jean-Marie Rakic; Agnès Noel
Journal:  Nat Protoc       Date:  2013-10-17       Impact factor: 13.491

7.  Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14.

Authors:  Mariusz Malinowski; Katarzyna Pietraszek; Corinne Perreau; Mateusz Boguslawski; Véronique Decot; Jean-François Stoltz; Laurent Vallar; Jolanta Niewiarowska; Czeslaw Cierniewski; François-Xavier Maquart; Yanusz Wegrowski; Stéphane Brézillon
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

8.  MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.

Authors:  Mervi Toriseva; Matti Laato; Olli Carpén; Suvi T Ruohonen; Eriika Savontaus; Masaki Inada; Stephen M Krane; Veli-Matti Kähäri
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

9.  An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.

Authors:  Hong Li; Yu-sheng Wang
Journal:  Mol Vis       Date:  2013-05-29       Impact factor: 2.367

Review 10.  Emerging options for the management of age-related macular degeneration with stem cells.

Authors:  Ingrid Mooney; James Lamotte
Journal:  Stem Cells Cloning       Date:  2010-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.